1Yao JC, Hassan M, Phan A ,el a/.One hundren yea~ after car- cinoid :epidemiology of and prognostic factors lbr neuroendo- crine tumors in 35,825 cases in the United Slates[ J] .J Clin Ctn,,ol, 2008,26 ( 18 ) : 3063- 3072.
4Nikfarjam M,Warshaw AL,Axelrod L,et al.Improved contemporary surgical management of insulinomas:a 25-year experience at the Massachusetts General Hospital.Ann Surg,2008,247:165-172.
5Tucker ON,Crotty PL,Conlon KC.The management of insulinoma.Br J Surg,2006,93:264-275.
6Shin JJ,Gorden P,Libutti SK.Insulinoma:pathophysiology,localization and management.Future Oncol,2010,6:229-237.
7Ehehalt F,Saeger HD,Schmidt CM,et al.Neuroendocrine tumors of the pancreas.Oncologist,2009,14:456-467.
8Placzkowski KA,Vella A,Thompson GB,et al.Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic,1987-2007.J Clin Endocrinol Metab,2009,94:1069-1073.
9Hiramoto JS,Feldstein VA,LaBerge JM,et al.Intraoperative ultrasound and preoperative localization detects all occult insulinomas.Arch Surg,2001,136:1020-1025.
10Ramage JK,Davies AH,Ardill J,et al.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.Gut,2005,54(Suppl 4):1-16.
